NTLA Notícias Forex
Intellia Therapeutics Appoints Edward Dulac To Succeed Glenn Goddard As CFO
Gene editing company Intellia Therapeutics, Inc. (NTLA) announced Wednesday the appointment of Edward Dulac as Executive Vice President, Chief Financial Officer (CFO), and Treasurer, effective July 22, 2024.
RTTNews
|
879 dias atrás
